| Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (mcl-1) … |
2022-11-13 |
2023-1-01 |
|
| Cdk inhibitors and their use as pharmaceuticals |
2022-9-30 |
2023-4-06 |
|
| Brm targeting compounds and associated methods of use |
2022-7-12 |
2023-1-19 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2022-3-16 |
2022-5-01 |
|
| Cdk inhibitors and their use as pharmaceuticals |
2022-3-08 |
2022-5-01 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2022-2-17 |
2022-6-09 |
|
| CDK Inhibitors And Their Use As Pharmaceuticals |
2021-12-17 |
2022-8-25 |
|
| Processes for making prmt5 inhibitors |
2021-12-09 |
2022-6-16 |
|
| Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5) |
2021-11-18 |
2022-5-19 |
|
| Brm targeting compounds and associated methods of use |
2021-11-08 |
2022-5-12 |
|
| CDK Inhibitors And Their Use As Pharmaceuticals |
2021-9-21 |
2022-3-24 |
|
| Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) … |
2021-8-17 |
2023-1-12 |
|
| Selective inhibitor of protein arginine methyltransferase 5 (prmt5) |
2021-8-11 |
2021-9-30 |
|
| Heterocycle cdk inhibitors and their use thereof |
2021-8-10 |
2022-2-17 |
|
| COMPOUNDS THAT TARGET BRM AND ASSOCIATED METHODS OF USE |
2021-6-09 |
2023-1-31 |
|
| BCL-2 inhibitors and their use as pharmaceuticals |
2021-4-27 |
2023-4-11 |
2023-4-11 |
| Bcl-2 inhibitors and their use as pharmaceuticals |
2021-4-27 |
2021-11-11 |
|
| Spiro-sulfonimidamide derivatives as inhibitors of myeloid cell leukemia-1 (mcl … |
2021-4-16 |
2021-10-21 |
|
| Selective inhibitors of protein arginine methyltransferase 5 |
2020-4-03 |
2020-10-08 |
|
| Selective inhibitors of protein arginine methyltransferase 5 |
2020-4-03 |
2020-10-08 |
|
| Selective inhibitors of protein arginine methyltransferase 5 |
2020-4-03 |
2022-2-09 |
|
| SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) |
2020-2-13 |
2021-10-13 |
|
| Bicyclic heterocyclic derivatives and their use as pharmaceuticals |
2019-12-13 |
2022-3-03 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
2019-4-05 |
2020-7-14 |
2020-7-14 |
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2018-10-26 |
2019-5-02 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2018-3-01 |
2018-9-07 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2018-3-01 |
2018-9-07 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2018-2-20 |
2018-8-23 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2018-2-20 |
2018-10-11 |
|
| Selective inhibitors of protein arginine methyl transferase 5 (prmt5) |
2017-11-07 |
2018-10-25 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2017-11-07 |
2018-5-11 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2017-10-18 |
2018-4-26 |
|
| Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
2017-6-15 |
2017-12-21 |
|
| Inhibiteurs de cdk et leur utilisation en tant que produits pharmaceutiques |
2022-9-30 |
2023-4-06 |
|
| Inibidor seletivo de proteína arginina metiltransferase 5 (prmt5) |
2020-2-13 |
2021-10-13 |
|